This website’s original language is English. For translation, click the globe icon or choose Translate in the menu.
10 matching records found
The Atlanta Braves are one of only a few publicly traded sports teams, which makes the argument for its sale a unique one in a year when two other MLB teams were sold at record valuations. On this episode of The Deal, Alex Rodriguez and Jason Kelly talk to the Founder and Portfolio Manager of Breach Inlet Capital Management, Chris Colvin about his sales pitch. Listen to their full conversation wherever you get your podcasts (Source: Bloomberg)
TPG Inc. has raised $10 billion in investor capital for a second private equity fund dedicated to climate strategies, according to people familiar with the matter.
The Securities and Exchange Commission staff issued a statement about valuing private assets as holdings become harder to sell and investor redemption requests surge. Kat Hidalgo has more on "Bloomberg Open Interest." (Source: Bloomberg)
For Ariel Bezalel, thinking about investing in French bonds brings to mind Greece more than 15 years ago.
After nearly a decade of waiting, India’s National Stock Exchange has finally gone public. But can NSE live up to years of hype and investor expectations? Rajesh Mascarenhas explains what’s behind the long-awaited debut. (Source: Bloomberg)
Essity AB is preparing to kick off the sales process for its consumer tissue business as soon as next month, according to people familiar with the matter, after activist investor Cevian Capital took a minority stake in the Swedish company.
Over the past three decades, investor Fang Fenglei has had a major role in shaping China’s capital markets. He worked with Morgan Stanley in the early 1990s to help create the country’s first joint venture investment bank – China International Capital Corp. Then, at the start of the millennium, he spearheaded the listing of state-owned giants in Hong Kong as CEO of Bank of China International, later chairing a China joint venture with Goldman Sachs. Now the chairman of Hopu Investments, Fang...
Novartis AG shareholder Artisan Partners said the Swiss drugmaker needs to shake up its board and improve dealmaking after its shares plunged following three major clinical trial setbacks, Reuters reported.